Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders List
H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading →

Read the article
no
Research
Research Collection: Breast Cancer
Our series of Faculty Opinions Essential Reading collections continues with a focus this time on Breast Cancer research. Breast cancer is the most commonly diagnosed cancer worldwide, with a new… Continue reading →

Read the article
Commercialization KOL Engagement
Medical Public Awareness Campaigns—Examples and Effectiveness
Medical public awareness campaigns are designed to distribute important healthcare messages to large populations. With over seven billion people in the world, it is necessary to find ways to share… Continue reading →

Read the article
Diversity & Inclusion Drug Development
Best-Fit Sites for Clinical Trials
When evaluating the feasibility of a clinical trial, it’s essential to consider what success means. This can mean defining criteria for your patient population, principal investigator (PI) qualifications, and… Continue reading →

Read the article
no
Research
The COVID-19 Essential Reading Collection
The next collection in our series of Faculty Opinions Essential Reading that we want to highlight is COVID-19. When the COVID-19 pandemic arrived, it disrupted nearly every aspect of our… Continue reading →

Read the article
Diversity & Inclusion
How to Build a Scalable Diversity Strategy
Put simply – in 2022, clinical trial diversity, equity and inclusion (DEI) was top of mind for the pharma and biotech industries, across all phases of drug and device… Continue reading →

Read the article
no

«‹4 5 678 9 10 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕